Abstract:Sarcopenia is a condition characterized by the age-related loss of skeletal muscle mass and function. The pathogenesis of the disease is influenced by chronic low-grade inflammation. However, the specific changes in the immune landscape changes of sarcopenic muscle are not yet fully understood. To gain insights into the immune cell composition and interactions, we combined single-nuclei RNA sequencing data, bulk RNA sequencing datasets, and comprehensive bioinformatic analyses on skeletal muscle samples from young, aged, and sarcopenic individuals. Histological staining was then performed on skeletal muscles to validate the distribution of immune cells in clinical samples. Overall, we analyzed the transcriptomes of 101,862 single nuclei, revealing a total of 10 major cell types and 6 subclusters of immune cell types within the human skeletal muscle tissues. Among the immune cells, macrophages constituted the largest immune fraction. A specific marker gene LYVE1 for skeletal muscle macrophages was further identified. Cellular subclasses included four distinct groups of resident macrophages, which play a different role in physiological or non-physiological conditions. Using bulk RNA sequencing data, we identified strong enrichment for a macrophage-rich inflammation in sarcopenia. Our findings demonstrate age-related changes in the composition and cross-talk of immune cells, which contribute to chronic inflammation. Furthermore, macrophages emerge as a potential therapeutic target, thus advancing our understanding of the pathogenesis of sarcopenia.

What problem does this paper attempt to address?

The paper aims to address the issue of immune microenvironment changes associated with age-related sarcopenia. Specifically, the study seeks to gain a deep understanding of the changes in the composition and interactions of immune cells in skeletal muscle during sarcopenia through transcriptome analysis and histological validation. The research combines single-nucleus RNA sequencing data, bulk RNA sequencing datasets, and comprehensive bioinformatics analysis to analyze skeletal muscle samples from young, elderly, and sarcopenic individuals. Additionally, the distribution of immune cells in clinical samples was validated through histological staining. The main research contents include: 1. **Cell Type Composition**: Identified the major cell types in skeletal muscle tissue through single-nucleus RNA sequencing and analyzed the changes in cell composition across different age groups. 2. **Immune Cell Composition**: Further subdivided immune cells into multiple subgroups and analyzed the expression characteristics and functional differences of each subgroup across different age groups. 3. **Intercellular Communication**: Explored the interactions between different cell types, particularly the changes in these interactions in aged muscle. 4. **Enrichment of Inflammatory Signaling Pathways**: Analyzed the functional and metabolic changes between sarcopenic patients and healthy controls using bulk RNA sequencing data, with a particular focus on the enrichment of inflammation-related signaling pathways. 5. **Characteristics of Immune Cell Infiltration**: Based on the expression levels of the LYVE1 gene, samples were divided into high-expression and low-expression groups, and the differences in the immune microenvironment between these two groups were further analyzed. Through these analyses, the study reveals the important role of immune cells in sarcopenia, particularly the key role of macrophages in chronic inflammation and muscle repair. This provides new perspectives for understanding the pathogenesis of sarcopenia and offers a theoretical basis for potential therapeutic strategies.

Characterizing the skeletal muscle immune microenvironment for sarcopenia using transcriptome analysis and histological validation